Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Penetrating wounds
MeSH D014950 - penetrating wounds
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014947:
Wounds and injuries
34 Companies
12 Drugs
$
Success rate
D014950:
Penetrating wounds
9 Companies
18 Drugs
$
Success rate
D014948:
Gunshot wounds
0 Companies
0 Drugs
Success rate
D014951:
Stab wounds
0 Companies
0 Drugs
Success rate
D015807:
Penetrating eye injuries
0 Companies
0 Drugs
Success rate
D020197:
Penetrating head injuries
0 Companies
0 Drugs
Success rate
D049248:
Decapitation
0 Companies
0 Drugs
Success rate
D056146:
Corpse dismemberment
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Ascorbic acid
,
Cyanocobalamin
,
Ergocalciferol
,
Folic acid
,
Riboflavin
,
Vitamin a
McGuff Pharmaceuticals
Ascorbic acid
Roche
Ascorbic acid
,
Biotin
,
Cyanocobalamin
,
Dexpanthenol
,
Ergocalciferol
,
Folic acid
,
Pyridoxine
,
Riboflavin
,
Vitamin a
Taro Pharmaceutical
Ascorbic acid
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use